BRIEF published on 10/29/2026 at 17:52, 22 days 14 hours ago IntegraGen: 2026 Half-Year Results Marked by Losses and Legal Proceedings Financial Results Treasury Court Of Appeal Judicial Reorganization IntegraGen
BRIEF published on 10/26/2026 at 17:03, 25 days 15 hours ago IntegraGen Maintains Its Operations Pending the Court of Appeal's Decision Shareholders Court Of Appeal Judicial Reorganization Genomics IntegraGen
BRIEF published on 10/05/2026 at 19:22, 1 month 15 days ago IntegraGen: Decision expected on the divestment plan Judicial Reorganization IntegraGen Commercial Court Takeover Bids Decision Expected
BRIEF published on 09/11/2026 at 20:45, 2 months 9 days ago IntegraGen: two takeover bids filed in receivership Judicial Reorganization Genomics IntegraGen Resumption Commercial Court Of Évry
BRIEF published on 06/15/2026 at 20:31, 5 months 5 days ago IntegraGen is heading towards receivership to ensure its survival. Sustainability Judicial Reorganization Genomics Industrial Partnerships Strategic Activities
BRIEF published on 02/20/2026 at 20:20, 9 months ago IntegraGen: Annual Review and Continued Strategic Refocusing Revenue Treasury Certifications Profitability Biopharma
BRIEF published on 10/29/2025 at 17:50, 1 year ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
BRIEF published on 07/02/2025 at 07:35, 1 year 4 months ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
PRESS RELEASE published on 07/02/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
BRIEF published on 01/15/2025 at 18:49, 1 year 10 months ago IntegraGen revenue down for 2024 Treasury Growth Turnover Genomics SeqOIA
Published on 11/20/2026 at 15:00, 17 hours 12 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 17 hours 22 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 18 hours 12 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 18 hours 42 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 18 hours 42 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 8 hours 26 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 21:36, 10 hours 35 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 12 hours 46 minutes ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 13 hours 8 minutes ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:34, 13 hours 37 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 14 hours 37 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 13 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 1 day 23 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing